Views & Analysis Who should pay for HTA? Part of the drive for strengthening EU cooperation on health technology assessment (HTA) is to tackle duplication of work
Views & Analysis To unlock innovation, pharma needs to be honest about failur... Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock inn
White Papers Sponsored Remote HCP engagement – still a struggle for life science co... Life science companies are failing to achieve their full digital potential, particularly when it comes to the use of remote channels for effective physician engagement.
Views & Analysis Digital Health roundup: GDPR, Babylon Health, and Nokia Richard Staines presents his weekly round-up of the latest digital health news
Views & Analysis How AI and blockchain can reduce corruption in Big Pharma Gunjan Bhardwaj gives his opinion how new technologies can help reduce corruption in the pharma industry.
Views & Analysis Medtech is key in fight against AMR Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
